Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etomidate versus remifentanil for induction in cataract surgery
IRCT20220309054238N1Phase 3Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- Apr 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial in cataract comparing Etomidate induction with Remifentanil induction (2 arms). Primary endpoints: Blood pressure, Pulse rate and 1 more. Started Apr 2022; status: completed.
02
Drugs
etomidateremifentanil
03
Conditions
cataract
Beyond the preview
Go deeper on IRCT20220309054238N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220309054238N1.